Affordable Access

Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.

Authors
  • Harada, N
  • Okajima, K
  • Kushimoto, S
Type
Published Article
Journal
Critical Care Medicine
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Sep 01, 1999
Volume
27
Issue
9
Pages
1958–1964
Identifiers
PMID: 10507625
Source
Medline
License
Unknown

Abstract

Gabexate mesilate reduced ischemia/reperfusion-induced hepatic injury not by inhibiting coagulation, but by inhibiting leukocyte activation.

Report this publication

Statistics

Seen <100 times